FDA Inspection 613021 — Hospira Worldwide, LLC
The FDA completed an inspection of Hospira Worldwide, LLC on September 18, 2009 in Pleasant Prairie, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 18, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pleasant Prairie, WI (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)